25 XP   0   0   10

AVROBIO Inc
Buy, Hold or Sell?

Let's analyse Avrobio together

PenkeI guess you are interested in AVROBIO Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of AVROBIO Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about AVROBIO Inc

I send you an email if I find something interesting about AVROBIO Inc.

Quick analysis of Avrobio (30 sec.)










What can you expect buying and holding a share of Avrobio? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.11
Expected worth in 1 year
$2.54
How sure are you?
24.1%

+ What do you gain per year?

Total Gains per Share
$0.43
Return On Investment
34.3%

For what price can you sell your share?

Current Price per Share
$1.26
Expected price per share
$1.19 - $1.31
How sure are you?
50%

1. Valuation of Avrobio (5 min.)




Live pricePrice per Share (EOD)

$1.26

Intrinsic Value Per Share

$8.79 - $11.44

Total Value Per Share

$10.90 - $13.56

2. Growth of Avrobio (5 min.)




Is Avrobio growing?

Current yearPrevious yearGrowGrow %
How rich?$94.7m$108.7m-$15.5m-16.7%

How much money is Avrobio making?

Current yearPrevious yearGrowGrow %
Making money$3.2m-$12.2m$15.4m475.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Avrobio (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#382 / 1019

Most Revenue
#873 / 1019

Most Profit
#125 / 1019

Most Efficient
#330 / 1019

What can you expect buying and holding a share of Avrobio? (5 min.)

Welcome investor! Avrobio's management wants to use your money to grow the business. In return you get a share of Avrobio.

What can you expect buying and holding a share of Avrobio?

First you should know what it really means to hold a share of Avrobio. And how you can make/lose money.

Speculation

The Price per Share of Avrobio is $1.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avrobio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avrobio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.11. Based on the TTM, the Book Value Change Per Share is $0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.52 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avrobio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.20-15.5%0.075.4%-0.07-5.9%-0.35-27.7%-0.30-23.5%
Usd Book Value Change Per Share-0.18-14.4%0.118.6%-0.52-41.6%-0.03-2.4%0.075.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.18-14.4%0.118.6%-0.52-41.6%-0.03-2.4%0.075.8%
Usd Price Per Share1.36-1.21-0.90-8.60-9.28-
Price to Earnings Ratio-1.74--0.71--0.26--4.19--6.08-
Price-to-Total Gains Ratio-7.51--3.13--1.69--14.55--23.26-
Price to Book Ratio0.64-0.63-0.37-2.34-2.71-
Price-to-Total Gains Ratio-7.51--3.13--1.69--14.55--23.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.26
Number of shares793
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.11-0.03
Usd Total Gains Per Share0.11-0.03
Gains per Quarter (793 shares)85.60-24.26
Gains per Year (793 shares)342.39-97.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103423320-97-107
206856740-194-204
30102710160-291-301
40137013580-388-398
50171217000-485-495
60205420420-582-592
70239723840-679-689
80273927260-776-786
90308130680-873-883
100342434100-970-980

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%3.026.00.010.3%3.026.00.010.3%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%4.016.00.020.0%7.019.03.024.1%7.019.03.024.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%4.016.00.020.0%7.019.03.024.1%7.019.03.024.1%

Fundamentals of Avrobio

About AVROBIO Inc

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are harvested from the patient and then modified with a lentiviral vector to insert the equivalent of a functional copy of the gene that is mutated in the target disease. The company's pipeline includes AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of Gaucher disease type 1, as well as to treat Gaucher disease type 3; AVR-RD-03 that is in preclinical stage for the treatment of Pompe disease; AVR-RD-04, which is in phase 1/2 clinical trial for the treatment of cystinosis; and AVR-RD-05 that is in preclinical stage for the treatment of Hunter syndrome. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 01:36:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of AVROBIO Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avrobio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AVROBIO Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--196.9%+196.9%
TTM--211.2%+211.2%
YOY--279.3%+279.3%
5Y--436.8%+436.8%
10Y--599.3%+599.3%
1.1.2. Return on Assets

Shows how efficient Avrobio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • -8.7% Return on Assets means that Avrobio generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AVROBIO Inc:

  • The MRQ is -8.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.7%TTM-1.7%-7.0%
TTM-1.7%YOY-5.7%+4.0%
TTM-1.7%5Y-9.0%+7.3%
5Y-9.0%10Y-21.3%+12.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.7%-13.6%+4.9%
TTM-1.7%-12.9%+11.2%
YOY-5.7%-11.9%+6.2%
5Y-9.0%-14.2%+5.2%
10Y-21.3%-16.2%-5.1%
1.1.3. Return on Equity

Shows how efficient Avrobio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • -9.3% Return on Equity means Avrobio generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AVROBIO Inc:

  • The MRQ is -9.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.3%TTM-5.1%-4.2%
TTM-5.1%YOY-6.3%+1.2%
TTM-5.1%5Y-10.5%+5.4%
5Y-10.5%10Y-19.4%+8.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.3%-17.0%+7.7%
TTM-5.1%-16.1%+11.0%
YOY-6.3%-15.4%+9.1%
5Y-10.5%-20.0%+9.5%
10Y-19.4%-21.1%+1.7%

1.2. Operating Efficiency of AVROBIO Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avrobio is operating .

  • Measures how much profit Avrobio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AVROBIO Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--282.4%+282.4%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--475.2%+475.2%
10Y--624.7%+624.7%
1.2.2. Operating Ratio

Measures how efficient Avrobio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AVROBIO Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.994-2.994
TTM-3.247-3.247
YOY-3.766-3.766
5Y-5.675-5.675
10Y-7.857-7.857

1.3. Liquidity of AVROBIO Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avrobio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 15.78 means the company has $15.78 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AVROBIO Inc:

  • The MRQ is 15.779. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.866. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ15.779TTM11.866+3.913
TTM11.866YOY9.278+2.588
TTM11.8665Y12.866-1.000
5Y12.86610Y11.435+1.432
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.7793.930+11.849
TTM11.8664.251+7.615
YOY9.2785.436+3.842
5Y12.8666.045+6.821
10Y11.4356.383+5.052
1.3.2. Quick Ratio

Measures if Avrobio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • A Quick Ratio of 15.47 means the company can pay off $15.47 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AVROBIO Inc:

  • The MRQ is 15.471. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.602. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ15.471TTM11.602+3.870
TTM11.602YOY8.800+2.802
TTM11.6025Y12.476-0.875
5Y12.47610Y10.931+1.545
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.4713.629+11.842
TTM11.6024.065+7.537
YOY8.8005.390+3.410
5Y12.4765.993+6.483
10Y10.9316.277+4.654

1.4. Solvency of AVROBIO Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avrobio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avrobio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that Avrobio assets are financed with 6.3% credit (debt) and the remaining percentage (100% - 6.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AVROBIO Inc:

  • The MRQ is 0.063. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.145. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.063TTM0.145-0.083
TTM0.145YOY0.223-0.077
TTM0.1455Y0.123+0.023
5Y0.12310Y0.268-0.145
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0630.332-0.269
TTM0.1450.333-0.188
YOY0.2230.268-0.045
5Y0.1230.366-0.243
10Y0.2680.390-0.122
1.4.2. Debt to Equity Ratio

Measures if Avrobio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 6.7% means that company has $0.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AVROBIO Inc:

  • The MRQ is 0.067. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.201. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.067TTM0.201-0.134
TTM0.201YOY0.290-0.089
TTM0.2015Y0.153+0.048
5Y0.15310Y0.139+0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0670.380-0.313
TTM0.2010.389-0.188
YOY0.2900.334-0.044
5Y0.1530.432-0.279
10Y0.1390.465-0.326

2. Market Valuation of AVROBIO Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avrobio generates.

  • Above 15 is considered overpriced but always compare Avrobio to the Biotechnology industry mean.
  • A PE ratio of -1.74 means the investor is paying $-1.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AVROBIO Inc:

  • The EOD is -1.609. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.736. Based on the earnings, the company is expensive. -2
  • The TTM is -0.707. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.609MRQ-1.736+0.128
MRQ-1.736TTM-0.707-1.029
TTM-0.707YOY-0.265-0.442
TTM-0.7075Y-4.193+3.486
5Y-4.19310Y-6.075+1.883
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.609-2.426+0.817
MRQ-1.736-2.552+0.816
TTM-0.707-2.656+1.949
YOY-0.265-4.143+3.878
5Y-4.193-6.252+2.059
10Y-6.075-6.108+0.033
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AVROBIO Inc:

  • The EOD is -1.760. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.899. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.008. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.760MRQ-1.899+0.140
MRQ-1.899TTM-1.008-0.891
TTM-1.008YOY-0.413-0.595
TTM-1.0085Y-4.719+3.711
5Y-4.71910Y-6.663+1.944
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.760-3.199+1.439
MRQ-1.899-3.259+1.360
TTM-1.008-3.552+2.544
YOY-0.413-5.617+5.204
5Y-4.719-8.326+3.607
10Y-6.663-8.689+2.026
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avrobio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.64 means the investor is paying $0.64 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AVROBIO Inc:

  • The EOD is 0.597. Based on the equity, the company is cheap. +2
  • The MRQ is 0.644. Based on the equity, the company is cheap. +2
  • The TTM is 0.628. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.597MRQ0.644-0.047
MRQ0.644TTM0.628+0.016
TTM0.628YOY0.370+0.258
TTM0.6285Y2.343-1.715
5Y2.34310Y2.710-0.367
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5971.947-1.350
MRQ0.6442.116-1.472
TTM0.6282.095-1.467
YOY0.3702.836-2.466
5Y2.3433.443-1.100
10Y2.7103.791-1.081
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of AVROBIO Inc.

3.1. Institutions holding AVROBIO Inc

Institutions are holding 61.286% of the shares of AVROBIO Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BML Capital Management LLC8.96054.1221400162700
2023-09-30TANG CAPITAL MANAGEMENT LLC7.86570.7633351268680768629.859
2023-12-31Newtyn Management LLC6.12240.73273417573417536.7088
2023-12-31Vanguard Group Inc3.58690.00011601834270001.7145
2023-12-31Acadian Asset Management LLC3.25640.00771454264-270825-15.6992
2023-12-31Aisling Capital Management LP2.26110.4097100977900
2023-12-31Renaissance Technologies Corp1.69940.001675894324047646.3821
2023-12-31Ikarian Capital, LLC1.60830.091571825900
2023-12-31Vazirani Asset Management LLC1.45553.632465000018172738.8079
2023-12-31Morgan Stanley - Brokerage Accounts1.40680.000162825910706020.5411
2023-12-31BlackRock Inc1.37650614708-7845-1.2601
2023-09-30Terrapin Asset Management LLC1.25120.985587875587870
2023-09-30Citadel Advisors Llc1.1420.000250998336290.7167
2023-12-31Affinity Asset Advisors, LLC1.11960.124250000000
2023-12-31Aldebaran Capital LLC1.01880.6335454986-15144-3.2212
2023-12-31FNY Investment Advisers, LLC0.89570.603540000017500077.7778
2023-12-31Geode Capital Management, LLC0.82070.0001366516134003.7948
2023-12-31Gabelli Securities Inc0.79040.09013530003530000
2023-12-31Gabelli Funds LLC0.7690.00363434213434210
2023-12-31Western Standard LLC0.70070.283331291225510.8219
Total 48.107612.47721484139+3254098+15.1%

3.2. Funds holding AVROBIO Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.96510.0001133067900
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.19770.000753748100
2024-02-29Fidelity Extended Market Index0.47370.0007212597-1030-0.4821
2023-12-31Bridgeway Ultra-Small Company0.31510.22191414002500021.4777
2023-12-31Bridgeway Ultra-Small Company Market0.19740.06488858767587321.8429
2023-09-30BlackRock Extended Mkt Composite0.18240.00098187100
2024-03-31BlackRock Extended Equity Market K0.15920.000671451260.0364
2024-02-29Fidelity Series Total Market Index0.10710.00014806400
2024-02-29Fidelity Total Market Index0.10690.00014795900
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0690.00073096800
2023-12-31Northern Trust Extended Eq Market Idx0.0680.00073052800
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0680.00073052800
2024-02-29Fidelity Nasdaq Composite Index0.06230.00022797400
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05540.000724872470.1893
2024-02-29Spartan Total Market Index Pool E0.0550.00012467100
2024-03-31BlackRock U.S. Equity Market F0.03540.0001158891540.9787
2023-12-31SSgA U.S. Extended Market Index Class I0.03320.00081490000
2024-03-31State St US Extended Mkt Indx NL Cl C0.03320.0011490000
2024-02-29Vanguard U.S. Eq Idx £ Acc0.02910.00011307400
2024-02-29Spartan Extended Market Index Pool E0.02430.000610895103010.441
Total 6.23750.29562799288+92814+3.3%

3.3. Insider Transactions

Insiders are holding 1.654% of the shares of AVROBIO Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-07-07Philip J. VickersBUY48008.35

4. Summary

4.1. Key Performance Indicators

The key performance indicators of AVROBIO Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1810.108-268%-0.524+190%-0.031-83%0.073-349%
Book Value Per Share--2.1122.077+2%2.424-13%3.539-40%2.791-24%
Current Ratio--15.77911.866+33%9.278+70%12.866+23%11.435+38%
Debt To Asset Ratio--0.0630.145-57%0.223-72%0.123-49%0.268-77%
Debt To Equity Ratio--0.0670.201-67%0.290-77%0.153-56%0.139-52%
Dividend Per Share----0%-0%-0%-0%
Eps---0.1960.068-389%-0.075-62%-0.349+78%-0.296+51%
Free Cash Flow Per Share---0.179-0.352+97%-0.544+204%-0.480+168%-0.377+111%
Free Cash Flow To Equity Per Share---0.178-0.442+148%-0.543+205%-0.126-29%0.010-1867%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--11.444--------
Intrinsic Value_10Y_min--8.789--------
Intrinsic Value_1Y_max---1.497--------
Intrinsic Value_1Y_min---1.472--------
Intrinsic Value_3Y_max---2.482--------
Intrinsic Value_3Y_min---2.410--------
Intrinsic Value_5Y_max---1.039--------
Intrinsic Value_5Y_min---1.138--------
Market Cap56524230.000-8%61010280.00054394477.763+12%40322860.425+51%385767776.138-84%416221133.198-85%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.597-8%0.6440.628+3%0.370+74%2.343-73%2.710-76%
Pe Ratio-1.609+7%-1.736-0.707-59%-0.265-85%-4.193+141%-6.075+250%
Price Per Share1.260-8%1.3601.213+12%0.899+51%8.599-84%9.278-85%
Price To Free Cash Flow Ratio-1.760+7%-1.899-1.008-47%-0.413-78%-4.719+148%-6.663+251%
Price To Total Gains Ratio-6.962+7%-7.515-3.126-58%-1.686-78%-14.551+94%-23.263+210%
Quick Ratio--15.47111.602+33%8.800+76%12.476+24%10.931+42%
Return On Assets---0.087-0.017-80%-0.057-34%-0.090+3%-0.213+146%
Return On Equity---0.093-0.051-45%-0.063-32%-0.105+13%-0.194+109%
Total Gains Per Share---0.1810.108-268%-0.524+190%-0.031-83%0.073-349%
Usd Book Value--94739000.00093158000.000+2%108741500.000-13%158764400.000-40%125223586.207-24%
Usd Book Value Change Per Share---0.1810.108-268%-0.524+190%-0.031-83%0.073-349%
Usd Book Value Per Share--2.1122.077+2%2.424-13%3.539-40%2.791-24%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.1960.068-389%-0.075-62%-0.349+78%-0.296+51%
Usd Free Cash Flow---8031000.000-15799500.000+97%-24406000.000+204%-21527050.000+168%-16913206.897+111%
Usd Free Cash Flow Per Share---0.179-0.352+97%-0.544+204%-0.480+168%-0.377+111%
Usd Free Cash Flow To Equity Per Share---0.178-0.442+148%-0.543+205%-0.126-29%0.010-1867%
Usd Market Cap56524230.000-8%61010280.00054394477.763+12%40322860.425+51%385767776.138-84%416221133.198-85%
Usd Price Per Share1.260-8%1.3601.213+12%0.899+51%8.599-84%9.278-85%
Usd Profit---8785000.0003249000.000-370%-12213750.000+39%-17383100.000+98%-14390862.069+64%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.1810.108-268%-0.524+190%-0.031-83%0.073-349%
 EOD+3 -5MRQTTM+17 -12YOY+19 -105Y+15 -1410Y+15 -14

4.2. Fundamental Score

Let's check the fundamental score of AVROBIO Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.609
Price to Book Ratio (EOD)Between0-10.597
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than115.471
Current Ratio (MRQ)Greater than115.779
Debt to Asset Ratio (MRQ)Less than10.063
Debt to Equity Ratio (MRQ)Less than10.067
Return on Equity (MRQ)Greater than0.15-0.093
Return on Assets (MRQ)Greater than0.05-0.087
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of AVROBIO Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.914
Ma 20Greater thanMa 501.269
Ma 50Greater thanMa 1001.289
Ma 100Greater thanMa 2001.317
OpenGreater thanClose1.280
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets101,093
Total Liabilities6,354
Total Stockholder Equity94,739
 As reported
Total Liabilities 6,354
Total Stockholder Equity+ 94,739
Total Assets = 101,093

Assets

Total Assets101,093
Total Current Assets100,261
Long-term Assets832
Total Current Assets
Cash And Cash Equivalents 98,303
Other Current Assets 1,958
Total Current Assets  (as reported)100,261
Total Current Assets  (calculated)100,261
+/-0
Long-term Assets
Property Plant Equipment 432
Long-term Assets Other 400
Long-term Assets  (as reported)832
Long-term Assets  (calculated)832
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,354
Long-term Liabilities0
Total Stockholder Equity94,739
Total Current Liabilities
Short-term Debt 878
Accounts payable 27
Other Current Liabilities 5,449
Total Current Liabilities  (as reported)6,354
Total Current Liabilities  (calculated)6,354
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -477,275
Other Stockholders Equity 572,010
Total Stockholder Equity (as reported)94,739
Total Stockholder Equity (calculated)94,739
+/-0
Other
Capital Stock4
Cash and Short Term Investments 98,303
Common Stock Shares Outstanding 44,654
Liabilities and Stockholders Equity 101,093
Net Debt -97,425
Net Invested Capital 94,739
Net Working Capital 93,907
Property Plant and Equipment Gross 5,790
Short Long Term Debt Total 878



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
5,400
0
0
0
7,022
60,216
158,730
143,272
133,479
117,368
101,989
217,205
200,514
269,728
255,568
233,255
271,234
245,912
238,095
216,453
203,837
175,343
146,244
129,497
103,949
83,005
133,835
110,522
101,093
101,093110,522133,83583,005103,949129,497146,244175,343203,837216,453238,095245,912271,234233,255255,568269,728200,514217,205101,989117,368133,479143,272158,73060,2167,0220005,400
   > Total Current Assets 
5,376
0
0
0
6,308
58,481
156,147
140,078
130,020
113,679
98,188
213,707
195,701
265,347
251,020
228,986
267,242
242,064
233,519
211,658
199,145
170,921
142,081
126,233
99,675
72,326
128,843
109,170
100,261
100,261109,170128,84372,32699,675126,233142,081170,921199,145211,658233,519242,064267,242228,986251,020265,347195,701213,70798,188113,679130,020140,078156,14758,4816,3080005,376
       Cash And Cash Equivalents 
5,357
0
0
0
5,963
57,928
155,015
138,577
126,302
108,476
90,348
206,362
187,043
257,695
244,380
219,546
259,682
233,027
226,438
201,369
189,567
161,663
132,409
115,968
92,563
72,326
124,689
105,842
98,303
98,303105,842124,68972,32692,563115,968132,409161,663189,567201,369226,438233,027259,682219,546244,380257,695187,043206,36290,348108,476126,302138,577155,01557,9285,9630005,357
       Short-term Investments 
0
0
0
0
0
0
0
396
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003960000000
       Net Receivables 
0
0
0
0
0
0
0
0
1,545
1,468
1,712
2,120
2,140
2,183
2,139
2,366
2,562
2,739
2,332
2,662
2,697
2,844
2,960
2,984
269
270
270
0
0
002702702692,9842,9602,8442,6972,6622,3322,7392,5622,3662,1392,1832,1402,1201,7121,4681,54500000000
       Other Current Assets 
19
0
0
0
60
237
294
469
3,718
475
329
247
8,658
966
997
1,163
7,560
387
516
522
9,578
805
555
765
7,112
845
792
805
1,958
1,9588057928457,1127655558059,5785225163877,5601,1639979668,6582473294753,7184692942376000019
   > Long-term Assets 
0
0
0
0
714
1,735
2,583
3,194
3,459
3,689
3,801
3,498
4,813
4,381
4,548
4,269
3,992
3,848
4,576
4,795
4,692
4,422
4,163
3,264
4,274
10,679
4,992
1,352
832
8321,3524,99210,6794,2743,2644,1634,4224,6924,7954,5763,8483,9924,2694,5484,3814,8133,4983,8013,6893,4593,1942,5831,7357140000
       Property Plant Equipment 
0
0
0
0
349
604
2,050
2,306
2,634
2,864
2,741
2,673
3,696
3,407
3,580
3,312
3,064
2,930
3,990
4,219
4,126
3,867
3,618
3,223
3,951
5,431
4,552
912
432
4329124,5525,4313,9513,2233,6183,8674,1264,2193,9902,9303,0643,3123,5803,4073,6962,6732,7412,8642,6342,3062,0506043490000
       Long-term Assets Other 
0
0
0
0
365
1,131
533
888
825
825
1,060
825
1,117
974
968
957
928
918
586
576
566
555
53
41
323
4,965
40
40
400
40040404,96532341535555665765869189289579689741,1178251,0608258258885331,1313650000
> Total Liabilities 
979
0
0
0
30,157
6,180
10,412
6,163
11,295
10,580
9,355
10,445
14,501
13,203
15,781
25,383
16,890
12,982
17,103
22,884
34,361
32,180
27,901
31,407
28,579
30,007
11,798
7,664
6,354
6,3547,66411,79830,00728,57931,40727,90132,18034,36122,88417,10312,98216,89025,38315,78113,20314,50110,4459,35510,58011,2956,16310,4126,18030,157000979
   > Total Current Liabilities 
891
0
0
0
2,625
5,061
9,631
5,427
10,606
9,935
8,765
9,910
14,017
12,773
15,411
25,052
16,614
12,768
16,953
22,794
19,386
17,130
12,785
16,192
12,116
11,672
11,664
7,559
6,354
6,3547,55911,66411,67212,11616,19212,78517,13019,38622,79416,95312,76816,61425,05215,41112,77314,0179,9108,7659,93510,6065,4279,6315,0612,625000891
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-183
0
999
2,627
2,250
1,647
878
8781,6472,2502,6279990-1830000000000000000000000
       Accounts payable 
340
0
0
0
527
2,052
4,193
1,582
2,784
3,458
2,572
1,408
3,949
2,135
2,619
2,311
2,682
2,698
2,029
2,966
3,486
4,037
28
1,814
384
591
1,071
910
27
279101,0715913841,814284,0373,4862,9662,0292,6982,6822,3112,6192,1353,9491,4082,5723,4582,7841,5824,1932,052527000340
       Other Current Liabilities 
551
0
0
0
2,098
3,009
5,438
3,845
7,822
6,477
6,193
8,502
10,068
10,638
12,792
22,741
13,932
10,070
14,924
19,828
15,900
13,093
12,757
14,378
10,733
8,454
4
1
5,449
5,449148,45410,73314,37812,75713,09315,90019,82814,92410,07013,93222,74112,79210,63810,0688,5026,1936,4777,8223,8455,4383,0092,098000551
   > Long-term Liabilities 
0
0
0
0
27,532
1,119
781
736
689
645
590
535
484
430
370
331
276
214
150
90
14,975
15,050
15,116
15,215
16,463
18,335
134
105
0
010513418,33516,46315,21515,11615,05014,975901502142763313704304845355906456897367811,11927,5320000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,276
15,356
0
0
0
00015,35615,276000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
183
0
188
352
134
105
0
010513435218801830000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
188
352
0
0
0
000352188000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
85
0
781
736
689
645
590
535
133
430
370
331
276
214
150
90
0
0
0
0
0
0
0
0
0
000000000901502142763313704301335355906456897367810850000
> Total Stockholder Equity
4,421
-4,579
0
0
-23,135
54,036
148,318
137,109
122,184
106,788
92,634
206,760
186,013
256,525
239,787
207,872
254,344
232,930
220,992
193,569
169,476
143,163
118,343
98,090
75,370
52,998
122,037
102,858
94,739
94,739102,858122,03752,99875,37098,090118,343143,163169,476193,569220,992232,930254,344207,872239,787256,525186,013206,76092,634106,788122,184137,109148,31854,036-23,13500-4,5794,421
   Common Stock
1
0
0
0
1
2
2
2
2
2
2
3
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
44444444444444443322222210001
   Retained Earnings Total Equity000-514,389-489,4320000-355,315-322,702-291,315-264,416-236,285-199,505-170,677-144,704-122,042-104,897-88,842-71,739-55,718-44,127000000
   Accumulated Other Comprehensive Income 0000000000-3,011-2,7120-2,132-1,818-1,517-1,234-989-774-575-384-200-71-25-450000
   Capital Surplus 
0
0
0
0
0
0
192,443
192,825
193,921
195,628
197,529
328,799
330,714
427,198
439,288
444,153
518,756
524,241
543,690
548,880
0
0
0
0
564,798
567,383
0
0
0
000567,383564,7980000548,880543,690524,241518,756444,153439,288427,198330,714328,799197,529195,628193,921192,825192,443000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
384
87,679
33,784
49,753
194,305
196,203
198,303
329,788
331,948
428,715
441,106
446,285
518,756
526,953
546,701
548,880
553,014
556,534
559,768
562,484
564,798
567,383
568,946
571,344
572,010
572,010571,344568,946567,383564,798562,484559,768556,534553,014548,880546,701526,953518,756446,285441,106428,715331,948329,788198,303196,203194,30549,75333,78487,6793840000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-617
Gross Profit-617-617
 
Operating Income (+$)
Gross Profit-617
Operating Expense-71,050
Operating Income-71,667-71,667
 
Operating Expense (+$)
Research Development47,083
Selling General Administrative23,967
Selling And Marketing Expenses0
Operating Expense71,05071,050
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,420
Other Finance Cost-3,825
Net Interest Income1,405
 
Pretax Income (+$)
Operating Income-71,667
Net Interest Income1,405
Other Non-Operating Income Expenses0
Income Before Tax (EBT)12,534-155,868
EBIT - interestExpense = -74,087
12,534
14,577
Interest Expense2,420
Earnings Before Interest and Taxes (EBIT)-71,66714,954
Earnings Before Interest and Taxes (EBITDA)-71,050
 
After tax Income (+$)
Income Before Tax12,534
Tax Provision-377
Net Income From Continuing Ops-4,09212,157
Net Income12,157
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses71,667
Total Other Income/Expenses Net84,201-1,405
 

Technical Analysis of Avrobio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avrobio. The general trend of Avrobio is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avrobio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AVROBIO Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.31 < 1.31 < 1.31.

The bearish price targets are: 1.2 > 1.2 > 1.19.

Tweet this
AVROBIO Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AVROBIO Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AVROBIO Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AVROBIO Inc. The current macd is -0.00848967.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avrobio price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Avrobio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Avrobio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
AVROBIO Inc Daily Moving Average Convergence/Divergence (MACD) ChartAVROBIO Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AVROBIO Inc. The current adx is 39.90.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Avrobio shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
AVROBIO Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AVROBIO Inc. The current sar is 1.19886272.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
AVROBIO Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AVROBIO Inc. The current rsi is 43.91. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
AVROBIO Inc Daily Relative Strength Index (RSI) ChartAVROBIO Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AVROBIO Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avrobio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
AVROBIO Inc Daily Stochastic Oscillator ChartAVROBIO Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AVROBIO Inc. The current cci is -36.502044.

AVROBIO Inc Daily Commodity Channel Index (CCI) ChartAVROBIO Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AVROBIO Inc. The current cmo is -16.71386666.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
AVROBIO Inc Daily Chande Momentum Oscillator (CMO) ChartAVROBIO Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AVROBIO Inc. The current willr is -66.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Avrobio is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
AVROBIO Inc Daily Williams %R ChartAVROBIO Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of AVROBIO Inc.

AVROBIO Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AVROBIO Inc. The current atr is 0.05177792.

AVROBIO Inc Daily Average True Range (ATR) ChartAVROBIO Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AVROBIO Inc. The current obv is 140,093,788.

AVROBIO Inc Daily On-Balance Volume (OBV) ChartAVROBIO Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AVROBIO Inc. The current mfi is 42.17.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
AVROBIO Inc Daily Money Flow Index (MFI) ChartAVROBIO Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AVROBIO Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

AVROBIO Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AVROBIO Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.914
Ma 20Greater thanMa 501.269
Ma 50Greater thanMa 1001.289
Ma 100Greater thanMa 2001.317
OpenGreater thanClose1.280
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Avrobio with someone you think should read this too:
  • Are you bullish or bearish on Avrobio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avrobio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AVROBIO Inc

I send you an email if I find something interesting about AVROBIO Inc.


Comments

How you think about this?

Leave a comment

Stay informed about AVROBIO Inc.

Receive notifications about AVROBIO Inc in your mailbox!